Atria (ATRAV) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
All business areas delivered improved results in H1 2024, with positive EBIT development across the group and successful commissioning of the new poultry plant in Finland.
Efficiency measures, successful investments, and a favorable sales structure contributed to profitability.
Major investments included the new Nurmo poultry plant and the acquisition of Gooh! in Sweden.
Sustainability initiatives advanced, with SBTi-approved emissions targets and progress in safety.
Financial highlights
H1 2024 net sales were €871.2 million, down 1.6% year-over-year; Q2 net sales were €454.3 million, down 0.6%.
H1 EBIT rose to €26.4 million (3.0% margin) from €20.9 million (2.4%) year-over-year; Q2 EBIT was €18.4 million (4.0% margin), up from €10.0 million (2.2%).
H1 earnings per share increased to €0.49 from €0.36; Q2 EPS was €0.39, up from €0.13.
Free cash flow for H1 was €1.9 million, a significant improvement from -€22.4 million a year ago.
Outlook and guidance
Adjusted EBIT guidance for 2024 was raised, now expected to exceed the previous year’s €49.6 million, driven by strong EBIT development and operational efficiency.
Uncertainty remains regarding consumer purchasing power and potential Chinese tariffs on European food imports.
The new poultry plant is fully operational and expected to enable future business expansion and cost-effective production.
Latest events from Atria
- Record net sales and EBIT, major investments, and positive 2026 outlook despite market risks.ATRAV
Q4 202512 Feb 2026 - Q3 2025 saw broad-based sales and EBIT growth, major investments, and a raised EBIT outlook.ATRAV
Q3 202523 Oct 2025 - Net sales and EBIT rose, driven by Sweden and poultry efficiency, but 2025 outlook is cautious.ATRAV
Q2 202517 Jul 2025 - Adjusted EBIT up 30% year-over-year, driven by Sweden's growth and operational efficiency.ATRAV
Q3 202413 Jun 2025 - EBIT and net sales rose, but 2025 outlook is cautious amid geopolitical and labor risks.ATRAV
Q1 20255 Jun 2025 - Record adjusted EBIT and strong segment gains, but 2025 outlook cautious amid risks.ATRAV
Q4 20245 Jun 2025